ACME Formulation is a finished-dose manufacturer based in India. It appears in 36 regulatory filings across 10 regulators, without an active US DMF or CEP on file. Its filings concentrate with EFDA (ET), NAFDAC (NG) and EDE (AE). Its GMP standing is certified by EMA, NAFDAC (NG) and MCAZ (ZW). Customs aggregates show $10.4M of exports covering 374 molecules to 45 destinations in 2025.
| Site | FDA FEI |
|---|---|
| CHANGODAR, United Arab Emirates | Not on file |
| Solan, India | 3016859498 |
| Nalagarh, India | Not on file |
| Atizapán de Zaragoza, Mexico | Not on file |
| Himachl Pradesh India, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EFDA (ET) | 8 | None |
| NAFDAC (NG) | 6 | 1 |
| EDE (AE) | 6 | None |
| TMDA (TZ) | 3 | None |
| CDSCO (India) | 3 | None |
| ARCSA (EC) | 3 | None |
| EMA | None | 3 |
| MCAZ (ZW) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $2.3M | 20 |
| 2025 | Not reported | $10.4M | 45 |
| 2024 | Not reported | $12.3M | 38 |
| 2023 | Not reported | $11.3M | 41 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. ACME Formulation comes back tiered against every other supplier able to file there.
Start for free